BLOG

What Risks and Side Effects Should You Ask About Before Adipose Stem Cell Therapy in Osaka?

Published 2026.10.04 7 min read

Hello, I am Dr. Hidenori Shimada of Grand Green Osaka Umekita Clinic in Osaka, Japan.

Anyone researching regenerative medicine abroad quickly finds enthusiastic claims. A more useful question is what could go wrong, and how a clinic plans to deal with it. This article explains the types of risks and side effects that are commonly discussed in connection with adipose-derived mesenchymal stem cell therapy, so that you can arrive at a consultation at Grand Green Osaka Umekita Clinic in Osaka with informed questions.

In short, no medical treatment is free of risk, and the evidence for stem cell therapy is still developing. Whether this treatment is appropriate for you can only be decided by a physician after an examination, and the points below are meant to support that conversation, not replace it.

Why It Helps to Think About Risks First

The therapy offered at the clinic uses mesenchymal stem cells taken from a small amount of your own fat tissue. The cells are cultured and expanded at a specialized facility and then returned to your body by intravenous infusion. It is an outpatient treatment, and it is provided as a self-pay (non-insured) medical service in Japan.

Because the treatment has several steps, from fat collection to culture to infusion, the possible risks are also spread across several steps. Looking at each step separately is a practical way to prepare your questions, and it avoids the common mistake of asking only about the infusion itself.

Risks Linked to the Fat Collection Step

Fat tissue is collected through a small incision under local anesthesia. As with other minor procedures of this kind, possible issues include bleeding, bruising, swelling, discomfort at the collection site, infection, and reactions to the anesthetic. Scarring at the incision site is also a possible concern.

Your own health history matters here. Medications that affect blood clotting, a history of delayed wound healing, skin conditions, and past allergic reactions to anesthetics are all things a physician needs to know. Bring a list of your current medicines, and if possible a short summary of your medical history in English or Japanese.

Risks Linked to Culture and Infusion

Because the cells are your own, the chance of rejection or allergic reaction is generally considered lower than with donor cells, but it is not zero. Reports in the medical literature on intravenous mesenchymal stem cell administration have described transient reactions such as fever, chills, headache, or mild discomfort around the time of infusion. Other reported concerns include infection if cells or materials are contaminated, and, in theory, effects related to the infused cells themselves that are not yet fully understood.

Long-term data are more limited than for established standard treatments. This is why it is reasonable to ask how the clinic monitors patients after infusion, what symptoms should prompt you to contact the clinic, and how follow-up is arranged if you return to your home country. Ask also how the culture facility controls quality and what happens if a cell preparation does not meet the required standards.

How Japan’s Regenerative Medicine Framework Fits In

In Japan, regenerative medicine of this kind is provided under the Act on the Safety of Regenerative Medicine. Under this framework, a medical institution submits a treatment plan that is reviewed by a certified committee and notified to the health authorities, and the cell processing is carried out at a facility designated for that purpose. This system sets rules for how treatment is planned, reviewed, and reported, including the reporting of health problems.

It is important to read this correctly. Operating within a legal framework describes how a treatment is regulated. It does not mean that the outcome is predictable or that risks are absent. You may wish to ask which plan the treatment is provided under, and how adverse events are recorded and reported.

Questions to Bring to Your Consultation

A written list helps, particularly when you are communicating across languages. Consider asking the following.

Is this treatment suitable for my condition and medical history, and what are the reasons to consider or not consider it?
What risks and side effects are associated with each step, and how common are they, to the extent that this is known?
What are the total costs, the number of treatment sessions, and the expected duration, including any costs for managing side effects?
How does this treatment relate to my current standard medical care, and should I continue my existing treatment?
What follow-up is offered, and how can I get help after I travel home?

Costs, risks, and side effects should be confirmed directly with the physician and in writing before you decide. The clinic’s treatment page also has sections on features, flow, fees, and frequently asked questions that you can read in advance.

Planning a Consultation From Abroad

Grand Green Osaka Umekita Clinic is located in the Umeda area of Osaka and provides information pages for international patients in multiple languages. If you are traveling from overseas, it is wise to ask your own doctor at home whether the treatment could interact with your existing conditions or medicines, and to share any relevant records with the clinic ahead of time.

Treat the first consultation as an opportunity to gather information, not as a commitment. A responsible discussion should cover the limits of current evidence as clearly as the potential benefits, and it should leave you free to decide on your own timeline. This treatment is not a substitute for standard medical care for any disease.

Summary

Adipose-derived stem cell therapy involves distinct risks at the fat collection, culture, and infusion steps, and the long-term evidence is still limited. Japan’s regenerative medicine law provides a regulatory structure, but it does not remove uncertainty. Suitability, fees, risks, and side effects should be confirmed with a physician at a consultation. Preparing specific questions in advance will help you make a calm and well-informed decision.

Where Risks Are Discussed

1Fat collectionLocal anesthesia, small incision
2Cell cultureQuality control at facility
3IV infusionOutpatient treatment
4Follow-upMonitoring after treatment

This figure is a conceptual diagram that organizes the content of the article

Learn more about Adipose-Derived Stem Cell Therapy

References

Supervising Physician

Director, Medical Corporation Shimada Clinic
Head of Clinical Practice, Grand Green Osaka Umekita Clinic

Hidenori Shimada

Graduated from the University of Tokushima Faculty of Medicine in 2005. After his initial residency, he obtained U.S. medical certification (ECFMG) and trained as a sub-intern in general surgery at the University of Washington. After completing the doctoral program at Kyoto University Graduate School of Medicine and working as a researcher at the Center for iPS Cell Research and Application (CiRA), Kyoto University, he founded Shimada Clinic in 2013. At Grand Green Osaka Umekita Clinic (https://umekitaclinic.org), he is engaged in a wide range of care, from internal medicine and pediatrics to cell therapy and aesthetic medicine.

* The physician supervision of this article covers its academic content only and does not constitute a recommendation of any specific treatment or product.

Back to article list › Back to Adipose-Derived Stem Cell Therapy ›